Business Description
Claritev Corp
NAICS : 923120
SIC : 5045
ISIN : US62548M1009
Share Class Description:
MPLNW: Warrants (01/03/2027)Total Employee Number:
3,000Description
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -15.93 | |||||
Debt-to-EBITDA | 9.8 | |||||
Interest Coverage | 0.29 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.45 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.6 | |||||
3-Year EBITDA Growth Rate | 42.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.97 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.06 | |||||
Days Sales Outstanding | 47.7 | |||||
Days Payable | 58.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | -12.67 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.29 | |||||
Operating Margin % | 11.57 | |||||
Net Margin % | -28.46 | |||||
EBITDA Margin % | 48.12 | |||||
ROA % | -5.77 | |||||
ROIC % | 1.86 | |||||
3-Year ROIIC % | 11.84 | |||||
ROC (Joel Greenblatt) % | 8.69 | |||||
ROCE % | 0.66 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 38.23 | |||||
PS Ratio | 0.62 | |||||
Price-to-Operating-Cash-Flow | 4.7 | |||||
EV-to-EBIT | 172.66 | |||||
EV-to-EBITDA | 11.11 | |||||
EV-to-Revenue | 5.34 | |||||
EV-to-FCF | -296.57 | |||||
Earnings Yield (Greenblatt) % | 0.58 | |||||
FCF Yield % | -2.84 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:MPLNW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Claritev Corp Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 2.34 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Claritev Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Claritev Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-23 16:30 | In 185 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-23 | In 184 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 08:00 | In 76 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 75 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-11 10:00 | -- | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:00 | -- | ||
| Second quarter earnings results for 2026 | 2026-08-07 | -- | ||
| Truist Securities Healthcare Disruptors & Digital Health Conference | 2026-06-24 13:00 | -- | ||
| Guidance call for 2026 | 2026-05-13 17:00 | -- | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:00 | -- |
Show
Entries
Claritev Corp Frequently Asked Questions
What is Claritev Corp(MPLNW)'s stock price today?
The current price of MPLNW is $0.00. The 52 week high of MPLNW is $2.34 and 52 week low is $0.00.
When is next earnings date of Claritev Corp(MPLNW)?
The next earnings date of Claritev Corp(MPLNW) is 2026-11-06 Est..
Does Claritev Corp(MPLNW) pay dividends? If so, how much?
Claritev Corp(MPLNW) does not pay dividend.
Press Release
Articles on Claritev Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers